201 related articles for article (PubMed ID: 25449155)
21. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
Furlan FC; Pereira BA; Sotto MN; Sanches JA
Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric identification of immunophenotypically aberrant T-cell clusters on skin shave biopsy specimens from patients with mycosis fungoides.
Horna P; Kurant D; Sokol L; Sotomayor EM; Moscinski L; Glass LF
Am J Clin Pathol; 2015 Jun; 143(6):785-96. PubMed ID: 25972320
[TBL] [Abstract][Full Text] [Related]
23. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
[TBL] [Abstract][Full Text] [Related]
24. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides.
Boztepe G; Sahin S; Ayhan M; Erkin G; Kilemen F
J Am Acad Dermatol; 2005 Aug; 53(2):242-6. PubMed ID: 16021117
[TBL] [Abstract][Full Text] [Related]
25. Excimer laser in the treatment of mycosis fungoides.
Deaver D; Cauthen A; Cohen G; Sokol L; Glass F
J Am Acad Dermatol; 2014 Jun; 70(6):1058-60. PubMed ID: 24775402
[TBL] [Abstract][Full Text] [Related]
26. [Mycosis fungoides. Results of helioclimate therapy in high mountains (Davos, 1,560)].
Tippel H; Engst R
Hautarzt; 1986 Aug; 37(8):450-3. PubMed ID: 3759452
[TBL] [Abstract][Full Text] [Related]
27. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
[TBL] [Abstract][Full Text] [Related]
28. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
29. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases.
Muniesa C; Estrach T; Pujol RM; Gallardo F; Garcia-Muret P; Climent J; Servitje O
J Am Acad Dermatol; 2010 Mar; 62(3):418-26. PubMed ID: 20079954
[TBL] [Abstract][Full Text] [Related]
30. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
[TBL] [Abstract][Full Text] [Related]
31. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
32. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
33. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
[TBL] [Abstract][Full Text] [Related]
34. [Mycosis fungoides. Clinical characteristics and treatment of 6 patients].
Dotterud LK; Aarstein K; Falk ES
Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1850-2. PubMed ID: 1853318
[TBL] [Abstract][Full Text] [Related]
35. Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides.
Yazıcı S; Bülbül Başkan E; Budak F; Oral B; Adim ŞB; Ceylan Kalin Z; Özkaya G; Aydoğan K; Saricaoğlu H; Tunali Ş
J Immunol Res; 2015; 2015():856340. PubMed ID: 26788525
[TBL] [Abstract][Full Text] [Related]
36. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
[TBL] [Abstract][Full Text] [Related]
37. Update on skin directed therapies in mycosis fungoides.
Lovgren ML; Scarisbrick JJ
Chin Clin Oncol; 2019 Feb; 8(1):7. PubMed ID: 30525757
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
Kelemen K; White CR; Gatter K; Braziel RM; Fan G
Am J Clin Pathol; 2010 Nov; 134(5):739-48. PubMed ID: 20959657
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
40. Poikilodermatous mycosis fungoides.
Bloom B; Marchbein S; Fischer M; Kamino H; Patel R; Latkowski JA
Dermatol Online J; 2012 Dec; 18(12):4. PubMed ID: 23286794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
